TOTFX
Price
$11.47
Change
-$0.04 (-0.35%)
Updated
Nov 13 closing price
Net Assets
929.61M
VMVIX
Price
$68.49
Change
-$0.77 (-1.11%)
Updated
Nov 13 closing price
Net Assets
31.8B
Interact to see
Advertisement

TOTFX vs VMVIX

Header iconTOTFX vs VMVIX Comparison
Open Charts TOTFX vs VMVIXBanner chart's image
Transamerica Mid Cap Value Opps R4
Price$11.47
Change-$0.04 (-0.35%)
VolumeN/A
Net Assets929.61M
Vanguard Mid-Cap Value Index Investor
Price$68.49
Change-$0.77 (-1.11%)
VolumeN/A
Net Assets31.8B
TOTFX vs VMVIX Comparison Chart in %
View a ticker or compare two or three
VS
TOTFX vs. VMVIX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TOTFX is a Buy and VMVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 31.8B vs. TOTFX (930M). VMVIX pays higher dividends than TOTFX: VMVIX (2.08) vs TOTFX (1.26). TOTFX was incepted earlier than VMVIX: TOTFX (9 years) vs VMVIX (19 years). TOTFX (0.99) is less costly to investors than VMVIX (0.19). TOTFX is a more actively managed with annual turnover of: 48.00 vs. VMVIX (19.00). VMVIX has a lower initial minimum investment than TOTFX: VMVIX (3000) vs TOTFX (5000). VMVIX annual gain was more profitable for investors over the last year : 2.82 vs. TOTFX (-4.70). VMVIX return over 5 years is better than : 56.50 vs. TOTFX (2.79).
TOTFXVMVIXTOTFX / VMVIX
Total Expense Ratio0.900.19474%
Annual Report Gross Expense Ratio0.990.19521%
Fund Existence9 years19 years-
Gain YTD6.9708.85179%
Front LoadN/AN/A-
Min. Initial Investment50003000167%
Min. Initial Investment IRAN/AN/A-
Net Assets930M31.8B3%
Annual Yield % from dividends1.262.0861%
Returns for 1 year-4.702.82-167%
Returns for 3 years2.3226.779%
Returns for 5 years2.7956.505%
Returns for 10 yearsN/A108.40-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTMX4.230.13
+3.17%
CytomX Therapeutics
BTCS2.980.05
+1.71%
BTCS
FWONA92.520.10
+0.11%
Liberty Media Corp
CLRB3.50-0.06
-1.69%
Cellectar Biosciences Inc
TENB27.51-0.54
-1.93%
Tenable Holdings